Literature DB >> 18549518

Sporogony of Tetracapsuloides bryosalmonae in the brown trout Salmo trutta and the role of the tertiary cell during the vertebrate phase of myxozoan life cycles.

D J Morris1, A Adams.   

Abstract

Tetracapsuloides bryosalmonae is the myxozoan that causes the commercially and ecologically important proliferative kidney disease of salmonid fish species. Immunohistochemistry and electron microscopy were used to examine the development of this parasite within the kidney of the brown trout Salmo trutta. The main replicative phase of T. bryosalmonae is a cell doublet composed of a primary cell and a single secondary cell. Engulfment of one secondary cell by another to form a secondary-tertiary doublet (S-T doublet) heralded the onset of sporogony whereupon the parasite migrated to the kidney tubule lumen. Within the tubule, the parasite transformed into a pseudoplasmodium and anchored to the tubule epithelial cells via pseudopodial extensions. Within each pseudoplasmodium developed a single spore, composed of 4 valve cells, 2 polar capsules and 1 sporoplasm. The pseudoplasmodia formed clusters suggesting that large numbers of spores develop within the fish. This examination of T. bryosalmonae suggests that the main replicative phase of freshwater myxozoans within vertebrates is via direct replication of cell doublets rather than through the rupturing of extrasporogonic stages, while tertiary cell formation relates only to sporogony. Taken in conjunction with existing phylogenetic data, 5 distinct sporogonial sequences are identified for the Myxozoa.

Entities:  

Mesh:

Year:  2008        PMID: 18549518     DOI: 10.1017/S0031182008004605

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  9 in total

1.  Cell formation by myxozoan species is not explained by dogma.

Authors:  David J Morris
Journal:  Proc Biol Sci       Date:  2010-04-14       Impact factor: 5.349

2.  Persistence of Tetracapsuloides bryosalmonae (Myxozoa) in chronically infected brown trout Salmo trutta.

Authors:  Ahmed Abd-Elfattah; Gokhlesh Kumar; Hatem Soliman; Mansour El-Matbouli
Journal:  Dis Aquat Organ       Date:  2014-08-21       Impact factor: 1.802

3.  Myxosporean hyperparasites of gill monogeneans are basal to the multivalvulida.

Authors:  Mark A Freeman; Andrew P Shinn
Journal:  Parasit Vectors       Date:  2011-11-24       Impact factor: 3.876

4.  3D Morphology, ultrastructure and development of Ceratomyxa puntazzi stages: first insights into the mechanisms of motility and budding in the Myxozoa.

Authors:  Gema Alama-Bermejo; James Emmanuel Bron; Juan Antonio Raga; Astrid Sibylle Holzer
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

5.  An epidemiological model for proliferative kidney disease in salmonid populations.

Authors:  Luca Carraro; Lorenzo Mari; Hanna Hartikainen; Nicole Strepparava; Thomas Wahli; Jukka Jokela; Marino Gatto; Andrea Rinaldo; Enrico Bertuzzo
Journal:  Parasit Vectors       Date:  2016-09-05       Impact factor: 3.876

Review 6.  The Malacosporean Myxozoan Parasite Tetracapsuloides bryosalmonae: A Threat to Wild Salmonids.

Authors:  Arun Sudhagar; Gokhlesh Kumar; Mansour El-Matbouli
Journal:  Pathogens       Date:  2019-12-23

7.  Fate of Tetracapsuloides bryosalmonae (Myxozoa) after infection of brown trout Salmo trutta and rainbow trout Oncorhynchus mykiss.

Authors:  Gokhlesh Kumar; Ahmed Abd-Elfattah; Mona Saleh; Mansour El-Matbouli
Journal:  Dis Aquat Organ       Date:  2013-11-25       Impact factor: 1.802

8.  Transcriptome profiling of posterior kidney of brown trout, Salmo trutta, during proliferative kidney disease.

Authors:  Arun Sudhagar; Reinhard Ertl; Gokhlesh Kumar; Mansour El-Matbouli
Journal:  Parasit Vectors       Date:  2019-11-29       Impact factor: 3.876

9.  Identification and Expression Profiling of Toll-Like Receptors of Brown Trout (Salmo trutta) during Proliferative Kidney Disease.

Authors:  Arun Sudhagar; Mansour El-Matbouli; Gokhlesh Kumar
Journal:  Int J Mol Sci       Date:  2020-05-26       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.